Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations

Overview of attention for article published in Molecular Cancer Therapeutics, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#39 of 5,232)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 15 news outlets
blogs: 1 blog

twitter: 8 X users

Readers on

mendeley: 47 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 23,624 followers.

RT @phsiao4: Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations Mol C…

Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations Mol Cancer Ther. 2021 Oct 4;20(12):2446–2456. https://t.co/cgZPq2XB9f https://t.co/1OavTuLzZj

RT @ChristianRolfo: Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations…

https://t.co/hot4T80TVC Interesting article shared by our NTRK CONNECT member @ChristianRolfo on #repotrectinib for #TRK fusion inhibition. @alexdrilon @BenjaminBesseMD #MedEd #PrecisionMedicine #NTRK

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.